Nano Delivers Big: Designing Molecular Missiles for Cancer Therapeutics
Open Access
- 13 January 2011
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 3 (1), 34-52
- https://doi.org/10.3390/pharmaceutics3010034
Abstract
Current first-line treatments for most cancers feature a short-list of highly potent and often target-blind interventions, including chemotherapy, radiation, and surgical excision. These treatments wreak considerable havoc upon non-cancerous tissue and organs, resulting in deleterious and sometimes fatal side effects for the patient. In response, this past decade has witnessed the robust emergence of nanoparticles and, more relevantly, nanoparticle drug delivery systems (DDS), widely touted as the panacea of cancer therapeutics. While not a cure, nanoparticle DDS can successfully negotiate the clinical payoff between drug dosage and side effects by encompassing target-specific drug delivery strategies. The expanding library of nanoparticles includes lipoproteins, liposomes, dendrimers, polymers, metal and metal oxide nano-spheres and -rods, and carbon nanotubes, so do the modes of delivery. Importantly, however, the pharmaco-dynamics and –kinetics of these nano-complexes remain an urgent issue and a serious bottleneck in the transition from bench to bedside. This review addresses the rise of nanoparticle DDS platforms for cancer and explores concepts of gene/drug delivery and cytotoxicity in pre-clinical and clinical contexts.This publication has 108 references indexed in Scilit:
- Noninvasive Imaging of Lipid Nanoparticle–Mediated Systemic Delivery of Small-Interfering RNA to the LiverMolecular Therapy, 2010
- Nanoparticle-based theranostic agentsAdvanced Drug Delivery Reviews, 2010
- Frontiers in cancer nanomedicine: directing mass transport through biological barriersTrends in Biotechnology, 2010
- PET/NIRF/MRI triple functional iron oxide nanoparticlesBiomaterials, 2010
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature, 2010
- Supramolecular Stacking of Doxorubicin on Carbon Nanotubes for In Vivo Cancer TherapyAngewandte Chemie, 2009
- PEG Branched Polymer for Functionalization of Nanomaterials with Ultralong Blood CirculationJournal of the American Chemical Society, 2009
- Targeted Killing of Cancer Cells in Vivo and in Vitro with EGF-Directed Carbon Nanotube-Based Drug DeliveryACS Nano, 2009
- Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2′-deoxycytidine analogNature Medicine, 2008
- The Hallmarks of CancerCell, 2000